The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Drug Solubility: Importance and Enhancement Techniques
Open accessAbstract
Solubility, the phenomenon of dissolution of solute in solvent to give a homogenous system, is one of the important parameters to achieve desired concentration of drug in systemic circulation for desired (anticipated) pharmacological response. Low aqueous solubility is the major problem encountered with formulation development of new chemical entities as well as for the generic development. More than 40% NCEs (new chemical entities) developed in pharmaceutical industry are practically insoluble in water. Solubility is a major challenge for formulation scientist. Any drug to be absorbed must be present in the form of solution at the site of absorption. Various techniques are used for the enhancement of the solubility of poorly soluble drugs which include physical and chemical modifications of drug and other methods like particle size reduction, crystal engineering, salt formation, solid dispersion, use of surfactant, complexation, and so forth. Selection of solubility improving method depends on drug property, site of absorption, and required dosage form characteristics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Cyclodextrin Drug Carrier Systems
Uekama, K., Hirayama, F., & Irie, T. (1998) · Chemical Reviews · doi:10.1021/cr970025p · Cited by 2,145
The Theory and Practice of Industrial Pharmacy
Lachman, L., Lieberman, H. A., & Kanig, J. L. (1970) · Virtual Defense Library (Ministerio de Defensa) · Cited by 1,838
Pharmaceutical Applications of Solid Dispersion Systems
Chiou, W. L., & Riegelman, S. (1971) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600600902 · Cited by 1,799
Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates
Blagden, N., de Matas, M., Gavan, P. T., & York, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.011 · Cited by 1,448
Nanosizing: a formulation approach for poorly-water-soluble compounds
Merisko-Liversidge, E., Liversidge, G. G., & Cooper, E. R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00251-8 · Cited by 1,263
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation
KECK, C., & MULLER, R. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.05.009 · Cited by 1,061
Vishweshwar, P., McMahon, J. A., Bis, J. A., & Zaworotko, M. J. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20578 · Cited by 968
Nanosuspensions: a promising drug delivery strategy
Patravale, V. B., Date, A. A., & Kulkarni, R. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023691 · Cited by 904
Drug-Like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization
Kerns, E. H., & Di, L. (2016) · Cited by 784
Cited by
Daina, A., Michielin, O., & Zoete, V. (2017) · Scientific Reports · doi:10.1038/srep42717 · Cited by 18,367
Biological Activity of Ionic Liquids and Their Application in Pharmaceutics and Medicine
Egorova, K. S., Gordeev, E. G., & Ananikov, V. P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00562 · Cited by 1,649
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
Smart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073
Advances in drug delivery systems, challenges and future directions
Ezike, T. C., Okpala, U. S., Onoja, U. L., Nwike, C. P., Ezeako, E. C., Okpara, O. J., Okoroafor, C. C., Eze, S. C., Kalu, O. L., Odoh, E. C., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17488 · Cited by 1,040
Khadka, P., Ro, J., Kim, H., Kim, I., Kim, J. T., Kim, H., Cho, J. M., Yun, G., & Lee, J. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.05.005 · Cited by 998
Baghel, S., Cathcart, H., & O'Reilly, N. J. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.10.008 · Cited by 970
Advances in Oral Drug Delivery
Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.618411 · Cited by 876
Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics
Bhalani, D. V., Nutan, B., Kumar, A., & Singh Chandel, A. K. (2022) · Biomedicines · doi:10.3390/biomedicines10092055 · Cited by 704
Kadurin, A., Nikolenko, S., Khrabrov, K., Aliper, A., & Zhavoronkov, A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00346 · Cited by 587
Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs
Censi, R., & Di Martino, P. (2015) · Molecules · doi:10.3390/molecules201018759 · Cited by 512
Structural Analysis of Molecular Materials Using the Pair Distribution Function
Terban, M. W., & Billinge, S. J. L. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00237 · Cited by 426
Zero-order drug delivery: State of the art and future prospects
Laracuente, M.-L., Yu, M. H., & McHugh, K. J. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.020 · Cited by 384
Ziaee, A., Albadarin, A. B., Padrela, L., Femmer, T., O'Reilly, E., & Walker, G. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.10.026 · Cited by 366
Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs
Liu, Y., Liang, Y., Yuhong, J., Xin, P., Han, J. L., Du, Y., Yu, X., Zhu, R., Zhang, M., Chen, W., et al. (2024) · Drug Design, Development and Therapy · doi:10.2147/dddt.s447496 · Cited by 365
The Use of Poly(N-vinyl pyrrolidone) in the Delivery of Drugs: A Review
Franco, P., & De Marco, I. (2020) · Polymers · doi:10.3390/polym12051114 · Cited by 355
Nanoscale Drug Delivery Systems: From Medicine to Agriculture
Vega-Vásquez, P., Mosier, N. S., & Irudayaraj, J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00079 · Cited by 323
Schiborr, C., Kocher, A., Behnam, D., Jandasek, J., Toelstede, S., & Frank, J. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300724 · Cited by 321
Foundations of gastrointestinal-based drug delivery and future developments
Chu, J. N., & Traverso, G. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00539-w · Cited by 289
Supercritical Fluid Technology: An Emphasis on Drug Delivery and Related Biomedical Applications
Kankala, R. K., Zhang, Y. S., Wang, S., Lee, C., & Chen, A. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700433 · Cited by 285
Maleki, A., Kettiger, H., Schoubben, A., Rosenholm, J. M., Ambrogi, V., & Hamidi, M. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.07.047 · Cited by 281
Late-stage Functionalization for Improving Drug-like Molecular Properties
Castellino, N. J., Montgomery, A. P., Danon, J. J., & Kassiou, M. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00797 · Cited by 264
Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers
Ristroph, K. D., & Prud'homme, R. K. (2019) · Nanoscale Advances · doi:10.1039/c9na00308h · Cited by 262
Nanocarrier for Poorly Water-Soluble Anticancer Drugs—Barriers of Translation and Solutions
Narvekar, M., Xue, H. Y., Eoh, J. Y., & Wong, H. L. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0107-x · Cited by 257
Zhuo, Y., Zhao, Y.-G., & Zhang, Y. (2024) · Molecules · doi:10.3390/molecules29204854 · Cited by 180
Nanocrystals: a perspective on translational research and clinical studies
Jarvis, M., Krishnan, V., & Mitragotri, S. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10122 · Cited by 162
Polymeric Micelles for Multi-Drug Delivery in Cancer
Cho, H., Lai, T. C., Tomoda, K., & Kwon, G. S. (2015) · AAPS PharmSciTech · doi:10.1208/s12249-014-0251-3 · Cited by 159
Model agnostic generation of counterfactual explanations for molecules
Wellawatte, G. P., Seshadri, A., & White, A. D. (2022) · Chemical Science · doi:10.1039/d1sc05259d · Cited by 143
Nanonization techniques to overcome poor water-solubility with drugs
Da Silva, F. L. O., Marques, M. B. D. F., Kato, K. C., & Carneiro, G. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1750591 · Cited by 136
Acid-activatable polymeric curcumin nanoparticles as therapeutic agents for osteoarthritis
Kang, C., Jung, E., Hyeon, H., Seon, S., & Lee, D. (2020) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2019.102104 · Cited by 120
Mouden, S., Klinkhamer, P. G. L., Choi, Y. H., & Leiss, K. A. (2017) · Phytochemistry Reviews · doi:10.1007/s11101-017-9502-8 · Cited by 67
Moghadam, S., & Larson, R. G. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00942 · Cited by 52
Shang, F.-F., Wang, J. Y., Xu, Q., Deng, H., Guo, H.-Y., Jin, X., Li, X., Shen, Q.-K., & Quan, Z.-S. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113474 · Cited by 30
Metadata
- Authors
- Savjani, K. T., Gajjar, A. K., & Savjani, J. K.
- Venue
- ISRN Pharmaceutics
- Publisher
- Wiley
- Published
- 2012-07-05
- Volume
- 2012
- Pages
- 1-10
- ISSN
- 2090-6145 (ISSN-L)
- 2090-6153
- OpenAlex
- W2151823004
- Cited by
- 2,004
- References
- 32
- FWCI
- 18.14
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.